Surgical Quality Improvement

Dermatology & Plastic Surgery Institute Outcomes

Dermatology & Plastic Surgery Institute Surgery ACS NSQIP Outcomes

January 1, 2021 – December 31, 2021

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s Dermatology & Plastic Surgery Institute surgery ACS NSQIP performance benchmarked against 457 participating sites.

Dermatology & Plastic Surgery (457 Sites)NObservedExpected
30 Day Morbidity3474.90%5.44%
Cardiac 3470.29%0.03%
Pneumonia3470.00%0.09%
Unplanned Intubation3470.00%0.01%
Deep Vein Thrombosis (DVT) / Pulmonary Embolus3470.58%0.38%
Urinary Tract Infection (UTI)3470.00%0.19%
Surgical Site Infection (SSI)3464.91%4.31%
Sepsis3470.86%0.38%
Return to Operating Room (ROR)3474.90%5.07%
Readmission 3473.46%2.99%

American College of Surgeons National Surgical Quality Improvement Program, 2022.
ACS NSQIP® Semiannual Report July 12, 2022, Chicago: American College of Surgeons.